Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

The pharmaceutical industry can be a tough business. Companies must innovate constantly to stay relevant because patents ...

Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS ...

The stock price has broken out from a multi-week consolidation with rising volumes. Narayana Hrudalaya share price is placed ...

Pharmaceutical giant Pfizer Inc. (NYSE: PFE) stock is trading back down near its pandemic lows. Every time it attempts to ...

Check the time stamp on this data. Updated AI-Generated Signals for Pfizer Inc. (PFE) available here: PFE.

Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Pfizer is expected to post earnings of $0.49 ...

And when a stock's fair value is higher than its current market price, investors tend ... to earnings estimates, Pfizer is rated Zacks Rank #2 (Buy). The chart below shows the evolution of the ...

Here's 2 High-Yielding S&P 500 Stocks to Buy in 2025, According to Wall Street. Prediction: This $43 Billion Bet Will Help Pfizer Stock Take Off in 2025.

The start of the new year is typically a time when people make big changes around health—and drug companies are no exception. Pfizer alone is raising prices on over 60 drugs, the most on the list.

Pfizer stock (NYSE: PFE) was up 5% on Tuesday, December 17, after the company announced an optimistic outlook for 2025. The company expects its revenue to be in the range of $61 billion to $64 ...

During this period, the Zacks Large Cap Pharmaceuticals industry, which Pfizer falls in, has gained 0%. The key question now is: What could be the stock's future direction? Although media reports or ...